Document ID: FDA-2009-N-0247-0128
Agency: fda
Document Type: Notice
Title: Food and Drug Administration Transparency Task Force; Reopening Comment Period
Posted Date: 2009-08-18T04:00Z

[Federal Register: August 18, 2009 (Volume 74, Number 158)]
[Notices]
[Page 41711-41712]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18au09-59]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0247]

Food and Drug Administration Transparency Task Force; Reopening
of Comment Period

AGENCY: Food and Drug Administration, HHS.

[[Page 41712]]

ACTION: Notice; reopening of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is reopening until
November 6, 2009, the comment period for the notice of public meeting
and request for comments that appeared in the Federal Register of June
3, 2009 (74 FR 26712). In the notice of public meeting and request for
comments, FDA's Transparency Task Force requested comments on ways in
which FDA can make useful and understandable information about FDA
activities and decision making more readily available to the public.
The agency is taking this action because the agency is planning a
second public meeting this fall and is reopening the comment period to
allow interested persons additional time to submit comments.

DATES: Submit written or electronic comments by November 6, 2009.

ADDRESSES: Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. Submit electronic comments to http://
www.regulations.gov. All such comments should be identified with the
docket number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Afia Asamoah, Office of the
Commissioner, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 1, rm. 2208, Silver Spring, MD 20993, 301-796-4625, FAX: 301-847-
3531, e-mail: Afia.Asamoah@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 3, 2009 (74
FR 26712), FDA published a notice of public meeting and request for
comments on ways in which FDA can make useful and understandable
information about FDA activities and decisionmaking more readily
available to the public, in a manner compatible with the agency's goal
of protecting confidential information, as appropriate. Interested
persons were given until August 7, 2009, to submit comments. The agency
is planning to hold a second meeting in the fall of 2009 about these
issues and is reopening the comment period until November 6, 2009. FDA
has also established an online blog at http://
fdatransparencyblog.fda.gov in which interested persons may provide
feedback on specific topics. The blog is expected to run through
November 2009.
    Interested persons may submit written or electronic comments to the
Division of Dockets Management (see ADDRESSES). Submit a single copy of
electronic comments to http://www.reguations.gov or two paper copies of
any mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.

    Dated: August 12, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-19778 Filed 8-17-09; 8:45 am]

BILLING CODE 4160-01-S